U.S. Office REITs Stock News

NasdaqGM:BRCB
NasdaqGM:BRCBHospitality

Black Rock Coffee Bar (BRCB) Margins Edge Into Profit Challenges Cautious Earnings Narratives

Black Rock Coffee Bar (BRCB) opened Q1 2026 with revenue of US$55.5 million and basic EPS of US$0.02, alongside net income of US$0.4 million. These results put fresh numbers behind a company that has recently moved into profitability on a trailing twelve month basis. The company has seen quarterly revenue move from US$42.8 million in Q4 2024 to US$51.5 million in Q3 2025 and then US$53.6 million in Q4 2025. Trailing twelve month EPS shifted from a loss of US$0.33 in Q2 2025 to a small profit...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Nebius Group (NBIS) Q1 Profitability Surge Tests Justification For Rich 77x P/E

Nebius Group (NasdaqGS:NBIS) has opened 2026 with Q1 revenue of US$399 million and Basic EPS of US$2.40, alongside net income of US$621.2 million, setting a clear marker after a volatile run of prior quarters. The company has seen revenue move from US$55.3 million in Q1 2025 and US$35.2 million in Q4 2024 to US$399 million in Q1 2026, with Basic EPS shifting from a loss of US$0.48 in Q1 2025 and a loss of US$0.58 in Q4 2024 to a profit of US$2.40. This puts the focus firmly on how sustainable...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

New Cooper Companies Director Adds Oversight As Shares Trade Below Targets

Cooper Companies (NasdaqGS:COO) has appointed Paul Keel to its Board of Directors. Keel will also serve on the Board’s Audit Committee. The appointment brings experience from senior executive roles at major medical technology and industrial companies. For investors watching Cooper Companies at a share price of $60.38, this board change comes after a period of weak stock performance. The stock is down 15.7% over the past 30 days, 25.6% year to date, and 25.9% over the past year, with a 37.9%...
NasdaqCM:SSII
NasdaqCM:SSIIMedical Equipment

SS Innovations International (SSII) Losses Challenge Bullish Narratives After Q1 2026 Results

SS Innovations International (NasdaqCM:SSII) opened 2026 with Q1 revenue of about US$11.1 million and a basic EPS loss of US$0.02, while trailing 12 month figures show revenue of roughly US$48.5 million and a basic EPS loss of US$0.05. Over the past reported quarters, revenue has ranged from about US$5.1 million in Q1 2025 to US$14.5 million in Q4 2025, with basic EPS losses moving between roughly US$0.00 and US$0.03 per share. Investors are therefore likely to focus on how efficiently that...
NasdaqGM:KROS
NasdaqGM:KROSBiotechs

Keros Therapeutics (KROS) Revenue Collapse To US$0.4 Million Challenges Bullish Growth Narratives

Keros Therapeutics (KROS) has just posted Q1 2026 results, with revenue of US$0.4 million, a basic EPS loss of US$1.21 and a net loss of US$23.7 million, setting the tone for the quarter at a share price of US$10.99. The company has seen quarterly revenue move from US$211.2 million in Q1 2025 to US$0.4 million in Q1 2026, while basic EPS shifted from a profit of US$3.66 to a loss of US$1.21. This puts the spotlight on how changes in revenue expectations and potential margin developments could...
NYSE:WWW
NYSE:WWWLuxury

Wolverine World Wide (WWW) Margin Improvement Reinforces Bullish Profitability Narrative

Wolverine World Wide (WWW) opened Q1 2026 with revenue of US$457.6 million and basic EPS of US$0.25, against a current share price of US$15.22. This sets a clear marker for how its latest quarter feeds into a steadily building earnings profile. The company has seen quarterly revenue move from US$412.3 million and EPS of US$0.13 in Q1 2025 to US$457.6 million and EPS of US$0.25 in Q1 2026. Trailing twelve month EPS stands at US$1.24 on revenue of roughly US$1.9 billion, giving investors a...
NYSE:BNT
NYSE:BNTInsurance

Brookfield Wealth Solutions (BNT) Q1 Loss And Margin Compression Challenge Bullish Earnings Narrative

Brookfield Wealth Solutions (BNT) has opened 2026 with a mixed Q1 print, reporting revenue of US$1.7b and a loss per share of US$1.83 on net income of US$609m. Over the last few quarters, revenue has moved from US$2.6b in Q1 2025 to US$3.1b in Q4 2025 before landing at US$1.7b in Q1 2026. Basic EPS has swung from a loss of US$0.90 to a profit of US$1.89 and US$1.18, then just US$0.02 ahead of the latest quarterly loss. With trailing 12 month EPS of US$1.45 and a net profit margin that has...
NYSEAM:NINE
NYSEAM:NINEEnergy Services

Nine Energy Service (NINE) Profit Swing To US$1.95 EPS Tests Cash Flow Bear Thesis

Nine Energy Service (NINE) has put up a sharp swing into profit in Q1 2026, with revenue of US$130.0 million and net income of US$106.6 million translating into basic EPS of US$1.95 for the quarter. Over the past five quarters, revenue has moved from US$150.5 million in Q1 2025 through a range of US$132.2 million to US$147.3 million, while EPS has shifted from a loss of US$0.18 per share in Q1 2025 to a profit of US$1.95 in Q1 2026. This sets up a story where margins rather than top line are...
NasdaqGM:ASTL
NasdaqGM:ASTLMetals and Mining

Algoma Steel Group Q1 Loss Narrows Yet Deep Trailing Losses Challenge Bullish Narratives

Algoma Steel Group’s Q1 2026 Results: Revenue Slides While Losses Narrow Algoma Steel Group (NasdaqGM:ASTL) opened fiscal 2026 with Q1 revenue of C$296.9 million and a basic EPS loss of C$1.46 per share, compared with a loss of C$0.61 per share in Q4 2024 on revenue of C$590.3 million. Over the past year, quarterly revenue has moved from C$517.1 million in Q1 2025 to C$296.9 million in Q1 2026, while net losses widened from C$24.5 million to C$159.4 million, setting a tough backdrop for the...
NasdaqCM:MDXH
NasdaqCM:MDXHBiotechs

MDxHealth (MDXH) Q1 Loss Near US$8.9 Million Reinforces Bearish Profitability Concerns

MDxHealth (NasdaqCM:MDXH) opened Q1 2026 with revenue of US$27.4 million and a basic EPS loss of US$0.17, alongside trailing 12 month revenue of US$111.0 million and a cumulative net loss of US$33.2 million that keeps the focus firmly on profitability. Over the last year, the company has seen revenue move from US$24.7 million in Q4 2024 to US$27.4 million in Q1 2026, while quarterly EPS has stayed in a tight range between a loss of US$0.14 and US$0.19, highlighting a situation where top line...
NasdaqGS:FOSL
NasdaqGS:FOSLLuxury

Fossil Group (FOSL) Margins Narrow To Near Breakeven Challenging Longstanding Loss Narratives

Fossil Group (FOSL) opened 2026 with Q1 revenue of US$224.8 million and a basic EPS loss of US$0.01, alongside a net loss of US$0.8 million. The trailing twelve months show revenue of US$995.9 million and a basic EPS loss of US$1.11 on a net loss of US$61.5 million. Over recent quarters, the company’s quarterly revenue moved from US$233.3 million in Q1 2025 to US$224.8 million in Q1 2026, while basic EPS shifted from a loss of US$0.33 to a much smaller loss of US$0.01. This puts the spotlight...
NasdaqGS:MGNX
NasdaqGS:MGNXBiotechs

MacroGenics (MGNX) Quarterly Loss Of US$36.8 Million Tests Bullish Path To Profitability

MacroGenics (MGNX) has opened Q1 2026 with revenue of about US$20.8 million and a basic EPS loss of roughly US$0.58, while trailing twelve month figures sit at revenue of about US$157.1 million and a basic EPS loss of around US$1.11. Over recent quarters, the company has reported revenue between US$13.2 million and US$72.8 million, with quarterly EPS ranging from a profit of about US$0.27 to losses such as US$0.65. This update keeps the focus on how the company is scaling revenue relative to...
NasdaqGS:HFWA
NasdaqGS:HFWABanks

Is Heritage Financial (HFWA) Pricing Looked At Differently After Recent Regional Bank Headlines?

Wondering whether Heritage Financial at around US$26.48 is offering genuine value or just looks reasonably priced on the surface? This article focuses on what the current share price might be implying about the company. The stock has slipped around 3.4% over the past week and 2.4% over the past month, yet it is still up 11.7% year to date and 13.4% over the past year, with a 3 year return of 85.0% and a 5 year return of 12.8%. Recent news coverage around regional banks has put more attention...
NasdaqCM:VRCA
NasdaqCM:VRCAPharmaceuticals

Verrica Pharmaceuticals (VRCA) Returns To Larger Q1 Loss Challenging Bullish Profitability Narratives

Verrica Pharmaceuticals (VRCA) opened Q1 2026 with revenue of about US$5.0 million and a basic EPS loss of US$0.45, while trailing twelve month figures show revenue of US$37.2 million and a basic EPS loss of US$1.31. Over the past year, the company reported quarterly revenue moving from US$3.4 million in Q1 2025 to US$14.3 million in Q3 2025, then settling around the US$5.0 million mark in Q1 2026. EPS moved from a loss of US$1.03 to a small profit of US$0.02 in Q2 2025 before returning to...
NasdaqGS:GILT
NasdaqGS:GILTCommunications

Gilat Satellite Networks (NasdaqGS:GILT) Margin Gains Reinforce Bullish Earnings Narratives In Q1 2026

Gilat Satellite Networks (NasdaqGS:GILT) opened 2026 with Q1 revenue of US$110.5 million and basic EPS of US$0.07. This set the tone for how its growth story is feeding through to the bottom line. The company reported revenue of US$92.0 million and an EPS loss of US$0.11 in Q1 2025, compared to revenue of US$110.5 million and an EPS profit of US$0.07 in Q1 2026. Trailing 12 month EPS is US$0.50 on revenue of US$470.1 million, which points to earnings growth supported by wider net margins. For...
NYSE:PSFE
NYSE:PSFEDiversified Financial

Paysafe (PSFE) Q1 Loss Deepens And Tests Bulls On Turnaround Narrative

Paysafe (PSFE) opened 2026 with Q1 revenue of US$442.7 million and a loss of US$36.5 million on a net income basis, which translated to basic EPS of a US$0.71 loss. Over the past five quarters, the company has seen revenue move from US$420.1 million in Q4 2024 to US$401 million in Q1 2025 and then to US$442.7 million in Q1 2026. Over the same period, basic EPS shifted from a profit of US$0.55 in Q4 2024 to losses of US$0.33 in Q1 2025 and US$0.71 in Q1 2026. For investors, the latest report...
NasdaqGS:JACK
NasdaqGS:JACKHospitality

Jack In The Box (JACK) Same Restaurant Sales Decline Challenges Bullish Turnaround Narrative

Jack in the Box (JACK) opened Q2 2026 with total revenue of US$254.3 million and basic EPS of US$0.65, alongside net income excluding extra items of US$12.5 million, setting the tone for how its turnaround story is tracking. The company has seen quarterly revenue move between US$265.7 million and US$371.1 million over the past five reported periods, while basic EPS has ranged from US$0.30 to US$1.63. This gives investors a clear view of how earnings power has shifted through recent quarters...
NasdaqGS:KRNT
NasdaqGS:KRNTMachinery

Kornit Digital (KRNT) Q1 Loss Of US$8.2 Million Challenges Recurring Revenue Stability Narrative

Kornit Digital (NasdaqGS:KRNT) opened Q1 2026 with revenue of US$48.5 million and a basic EPS loss of US$0.19, alongside a quarterly net loss of US$8.2 million, setting a cautious tone for the latest update. Over recent periods the company has seen revenue move from US$60.7 million in Q4 2024 to US$58.9 million in Q4 2025 and then to US$48.5 million in Q1 2026. EPS has swung between a profit of US$0.05 and losses such as US$0.17 and US$0.19, which keeps the spotlight firmly on margin pressure...
NYSE:AMTM
NYSE:AMTMProfessional Services

Amentum Holdings (AMTM) Q2 Margins Near 1% Test Bullish Earnings Rebound Narrative

Amentum Holdings (AMTM) has released its Q2 2026 results with revenue of US$3.5b and net income of US$54m, translating to basic EPS of US$0.22 for the quarter and trailing twelve month EPS of US$0.61. The company has seen quarterly revenue move between US$3.2b and US$3.9b over the past six reported periods, while quarterly basic EPS has ranged from US$0.02 to US$0.22. This sets up a picture of modest top line progress paired with gradually improving earnings power. For investors, the key...
NasdaqGS:ENTA
NasdaqGS:ENTABiotechs

Enanta Pharmaceuticals (ENTA) Q2 Loss Improvement Tests Bearish Profitability Narratives

Enanta Pharmaceuticals (ENTA) has just posted Q2 2026 results with revenue of US$17.2 million and a basic EPS loss of US$0.45, while trailing twelve month figures show revenue of US$69.2 million and a basic EPS loss of US$2.47. Over recent quarters the company has seen revenue move between US$14.9 million and US$18.6 million, with quarterly basic EPS losses ranging from roughly US$0.41 to US$1.06 and trailing twelve month net losses of US$62.0 million. For investors, the story this quarter is...
NasdaqCM:QUIK
NasdaqCM:QUIKSemiconductor

QuickLogic (QUIK) Q1 Losses Persist Despite Higher Revenue Challenging Bullish Profitability Narratives

QuickLogic (QUIK) opened Q1 2026 with revenue of about US$5.1 million and a basic EPS loss of US$0.13, setting the tone for another quarter where the top line and per share results remain firmly in focus for investors who track the stock through earnings season. Over the past year, the company has reported quarterly revenue in a range of roughly US$2.0 million to US$5.7 million, while basic EPS has ranged from a small profit of about US$0.01 per share to a quarterly loss of about US$0.24 per...
NYSEAM:ESP
NYSEAM:ESPElectrical

Espey Mfg. & Electronics (ESP) Non Cash Heavy 25.5% Margin Challenges Bullish Earnings Narratives

Espey Mfg. & Electronics (ESP) has reported another solid set of Q3 2026 numbers, with revenue of about US$11.4 million and basic EPS of roughly US$1.03, supported by trailing 12 month EPS of US$3.95 on revenue of around US$42.2 million. The company has seen quarterly revenue range between US$9.1 million and US$13.6 million over the past six periods, while basic EPS has moved between US$0.66 and US$1.10. This sets up the latest quarter against a backdrop of higher trailing earnings growth and...
NasdaqGS:MXCT
NasdaqGS:MXCTLife Sciences

MaxCyte (MXCT) EPS Loss Narrows In Q1 2026 Challenging Bearish Profitability Narratives

MaxCyte (NasdaqGS:MXCT) opened Q1 2026 with revenue of US$9.7 million and a basic EPS loss of US$0.04, while trailing 12 month figures show revenue of US$32.3 million and a basic EPS loss of US$0.37. The company has seen quarterly revenue move from US$10.4 million in Q1 2025 to US$9.7 million in Q1 2026, with net income moving from a loss of US$10.3 million to a loss of US$4.8 million over the same period. These figures frame the discussion for investors who are focused on how margins develop...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Profitable AI Stocks One Debt Free Earner One Quiet Chip Powerhouse

AI spending is no longer just a race to build the biggest models; it is increasingly about which companies can turn that investment into real earnings. With inflation pressures touching everything from fuel to freight, and central banks keeping rates higher for longer, cash generation and pricing power matter more than ever. The Profitable AI Stocks screener focuses on businesses already using AI to support profits rather than just promises. This article highlights 3 stocks from that list...